Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma

Anna L. Parksa Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USACorrespondence[email protected]

Swetha Kambhampatia Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Bita Fakhria Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Charalambos Andreadisa Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Lissa Graya Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Sandy W. Wonga Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Nina Shaha Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA

Margaret C. Fangb Division of Hospital Medicine, University of California, San Francisco, San Francisco, CA, USA

References